We found that tumor-infiltrating immune cells (TIIs) up-regulated their expression of the creatine transporter gene (Slc6a8 or CrT), which encodes a surface transporter controlling the uptake of creatine into a cell (Wyss and Kaddurah-Daouk, 2000). The gene discussed is SLC6A8; the disease is neoplasm.